Arcutis Biotherapeutics, Inc. ARQT Share-Based Payment Award Options Outstanding - Number
Share-Based Payment Award Options Outstanding - Number at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s share-based payment award options outstanding - number.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s share-based payment award options outstanding - number?
- Arcutis Biotherapeutics, Inc. (ARQT) reported share-based payment award options outstanding - number of 7.6M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s share-based payment award options outstanding - number changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s share-based payment award options outstanding - number increased by 9.2% year-over-year, from 7M to 7.6M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s share-based payment award options outstanding - number?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s share-based payment award options outstanding - number has grown at a 12.0% compound annual growth rate (CAGR), from 3.7M to 6.4M.
- What does share-based payment award options outstanding - number mean?
- This is the total count of stock options granted to employees and directors that remain unexercised at the reporting date. It reflects the total volume of potential equity claims currently held by the workforce. This metric is a key component in calculating fully diluted share counts.